Investors

Press Releases

Press Releases

Date Title  
Feb 19, 2020
SOUTH SAN FRANCISCO, Calif. , Feb. 19, 2020 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will report financial results for the fourth quarter and full year ended December 31, 2019 , on Wednesday, February 26, 2020 , after U.S.
Feb 03, 2020
SOUTH SAN FRANCISCO, Calif. , Feb. 03, 2020 (GLOBE NEWSWIRE) -- Global Blood Therapeutics , Inc. (GBT) (NASDAQ: GBT) today announced that on February 1, 2020 , the compensation committee of GBT’s board of directors granted seven new employees options to purchase an aggregate of 16,000 shares of the
Jan 08, 2020
SOUTH SAN FRANCISCO, Calif. , Jan. 08, 2020 (GLOBE NEWSWIRE) -- Global Blood Therapeutics , Inc. (GBT) (NASDAQ: GBT) today announced that on January 1, 2020 , the compensation committee of GBT’s board of directors granted 7 new employees options to purchase an aggregate of 11,200 shares of the
Jan 07, 2020
SOUTH SAN FRANCISCO, Calif. , Jan. 07, 2020 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will present at the 38 th Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2020 , at 4:00 p.m. Pacific Time .